CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,733 JPY | -4.69% |
|
-5.02% | -11.36% |
| 01/05 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
| 25/04 | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,966
JPY
Average target price
6,021
JPY
Spread / Average Target
+21.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.36% | 52.2B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- 4519 Stock
- Funds and ETFs Chugai Pharmaceutical Co., Ltd